Ester prodrugs of prostratin and related phorbol compounds
US8022103B2 · kind B2 · utility
1Cited by
14References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 13, 2006 |
| Grant date | Sep 20, 2011 |
| Priority date | — |
| Expiry date | Oct 12, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/86
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Ester prodrugs of phorbol compounds for the treatment of viral infections, neoplastic diseases, inflammatory reactions, and use as analgesics, wherein the phorbol compounds are derivatized with a -x-o-c(o)-R′ group linked to the 6-carbon of the phorbol residue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.